Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to review patients with E. coli infections at UPMC from January 1, 2004 to December 31, 2005 to determine if these infections have arisen in the community rather than in hospitals or nursing homes. The occurrence of such resistant isolates could be devastating if they were associated with bloodstream infection, such as sometimes accompanies urinary tract infection, since antibiotic resistant E. coli is not suspected in isolates coming from the community.


Clinical Trial Description

The following variables will be followed: age, sex, hospital location at the time of positive culture (ER, medical ward, ICU etc), prior hospitalization or nursing home admission, receipt of outpatient dialysis or other regular medical care (eg, outpatient chemotherapy), presence of invasive devices, receipt of antibiotics, including their type and whether they were adequate for the resistance profile of the organism, prior positive microbiologic cultures. ;


Study Design

Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT00298103
Study type Observational
Source University of Pittsburgh
Contact
Status Completed
Phase N/A
Start date February 2006
Completion date December 2015

See also
  Status Clinical Trial Phase
Completed NCT04574596 - Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia Coli